Skip to main content
. 2022 May 21;46(3):100538. doi: 10.1016/j.bj.2022.05.003

Table 2.

Bodyweight before treatment in Control and PCOS groups.

Groups BW before EV administration (g) BW following a 28-day administration of EV (g)
Control 180.33 ± 3.08 185.50 ± 3.03∗∗∗
PCOS 180.50 ± 3.08 204.33 ± 1.43∗∗∗

Results are presented as mean ± SEM (Control, n = 12 and PCOS, n = 36).

∗∗∗p < 0.001 vs control group.

Abbreviations: PCOS: Polycystic ovary syndrome; BW: Body weight; EV: Estradiol valerate.